Skip to main content
Clinical Trials/NCT05637840
NCT05637840
Completed
Not Applicable

Longitudinal Study of Metabolic Content of Human Urine

University of Wisconsin, Madison1 site in 1 country25 target enrollmentDecember 6, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Content of Urine
Sponsor
University of Wisconsin, Madison
Enrollment
25
Locations
1
Primary Endpoint
Change in inflammation
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this research study is to test the different components in urine and see if they can be matched to food, exercise and sleep that participants report. The researchers are trying to find out if urine would allow them to predict medical problems as they are happening. Participants are healthy volunteers who are willing to give urine samples on a daily basis, and can expect to be in the study for 28 days.

Detailed Description

The purpose of this research study is to analyze urine samples using Mass Spectrometry to identify metabolites that have the potential to be used for medical diagnosis. This data, along with data from wearable devices, will be combined and analyzed to correlate what an individual does on a daily basis with how their body metabolizes their choices. This type of data may provide insights into the origins and progression of diseases in a short time span.

Registry
clinicaltrials.gov
Start Date
December 6, 2022
End Date
November 18, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Must be 18 years or older
  • Be able to provide informed consent
  • Stated willingness to comply with all study procedures and have availability for the duration of the study

Exclusion Criteria

  • Presence of a condition(s) or diagnosis, either physical or psychological, that limits the ability to urinate in the collection apparatus
  • Individuals who do not consistently get at least 6 hours of sleep per night
  • Individuals who have a sleep disorder diagnosis.
  • Individuals who live in the state of New York

Outcomes

Primary Outcomes

Change in inflammation

Time Frame: Baseline to day 14

Changes in inflammation will be measured by hs-CRP via short-term sleep restriction.

Correlate biohealth data with concentrations of urine metabolites

Time Frame: Daily for 14 days

To explore connections between urine metabolite concentrations and others measures of health and lifestyle, biometric data will be collected using a FitBit watch (sleep and exercise), nutritional data (food logs) and a questionnaire (tobacco use). Urine will be analyzed using mass spectrometry to isolate metabolites. The metabolites will then be cross-referenced against databases of known metabolites in order to identify them and their disease associations.

Study Sites (1)

Loading locations...

Similar Trials